January 23, 2021
Data from an analysis of more than 3k women indicate increased frequency of vasomotor menopausal symptoms was associated with a 52% greater risk of incident cardiovascular disease.
January 16, 2021
An analysis of data from the UK Biobank cohort offers an overview of the risk reduction for cardiovascular disease derived from various levels and measurements of physical activity.
January 07, 2021
A study from UCL is providing clinicians with an estimate of excess cardiac deaths that occurred as a result of nonattendance to emergency department visits during the March 2020 peak of the pandemic.
January 05, 2021
A single-center trial from Europe is comparing plaque progression using CTA scans of patients randomized to intensive lifestyle intervention versus optimized medical therapy alone.
December 20, 2020
Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.
December 17, 2020
An analysis of more than 7k patients with CAN data from the ACCORD trial suggest intensive blood pressure and blood glucose control could reduce risk of cardiovascular autonomic neuropathy.
December 15, 2020
An analysis of more than 25 studies with more than 1 million patients is giving an overview of how the timing of a diabetes diagnosis can impact risk of complications later in life.
December 13, 2020
An analysis of 2 major studies is comparing the effects of bariatric surgery vs standard medical therapy on risk of cardiovascular disease events in obese teens with type 2 diabetes.
December 11, 2020
A resident from Penn State Hershey Medical Center offers perspective on the idea of using SGLT2 inhibitors for primary prevention in patients with type 2 diabetes.
December 04, 2020
An analysis of data over a 12-year period details the disparities in outcomes following first heart attack among female versus male patients.
December 02, 2020
An analysis of the Look AHEAD study by investigators at Johns Hopkins details associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.
November 29, 2020
An analysis of data from the Women's Health Initiative suggests spending more than 6.5 hours engaged in sedentary behaviors each day was linked to a 42% increase in risk of heart failure in older women.
November 23, 2020
An analysis of cardiovascular outcomes from FIDELIO-DKD suggest finerenone use was associated with a 14% reduction in negative cardiovascular outcomes.
November 21, 2020
In a recent column Gregory Weiss, MD, uses studies from AHA Scientific Sessions 2020 to compare the cost-effectiveness of antihyperglycemic agents for reducing cardiovascular events.
November 20, 2020
An analysis of CDC data presented at AHA Scientific Sessions 2020 suggests rates of high blood pressure complications among pregnant women nearly doubled during a period lasting from 2008-2017.
November 19, 2020
An analysis from AHA 2020 suggests an HbA1c screening protocol doubled the proportion of patients with known dysglycemia when treating patients with ST-elevation myocardial infarction.
November 17, 2020
Data from a pair of phase 3 trials detail the effects of sotagliflozin in patients with type 2 diabetes and other comorbidities, such as worsening heart failure and chronic kidney disease.
November 16, 2020
Pooled analysis of SUSTAIN 6 and PIONEER 6 trials indicates the impact of semaglutide impact on MACE was present regardless of baseline triglyceride levels among diabetic patients.
November 16, 2020
Professor John McMurray explains why he is not as displeased as some colleagues are with the uptake of SGLT2 inhibitor prescribing rates for patients with heart failure or chronic kidney disease.
November 12, 2020
An analysis of blood samples from more than 19k women offers greater insight into the relationship between premature menopause and cardiovascular disease risk in postmenopausal women.